Literature DB >> 25499194

The first reported case of central venous catheter-related fungemia caused by Cryptococcus liquefaciens.

Hiromu Takemura1, Hideaki Ohno2, Ikuo Miura3, Taeko Takagi4, Tadatomo Ohyanagi5, Hiroyuki Kunishima6, Akiko Okawara7, Yoshitsugu Miyazaki7, Hideki Nakashima8.   

Abstract

We describe a case of central venous catheter-related fungemia caused by Cryptococcus liquefaciens, a non-neoformans and non-gattii Cryptococcus, in a non-HIV patient. A 71-year-old man with diffuse large B-cell lymphoma receiving antineoplastic chemotherapy was febrile approximately 30 weeks after central venous port insertion, and C. liquefaciens was isolated from all three performed blood cultures as well as a central venous catheter tip culture. In vitro antifungal susceptibility tests showed that this yeast isolate was susceptible to low concentrations of amphotericin B, fluconazole, itraconazole and voriconazole yet was resistant to 5-fluorocytosine (MIC: >64 μg/ml), unlike Cryptococcus neoformans. Treatment of the patient with oral and intravenous voriconazole was effective and consistent with the susceptibility tests. Although non-neoformans and non-gattii Cryptococcus spp. are considered non-pathogenic environmental yeast, they may rarely be the causative agents of serious infections in humans, as in the present case.
Copyright © 2014 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (1-3) ß-D-glucan; Central venous catheter; Cryptococcus liquefaciens; Fungemia; Voriconazole

Mesh:

Year:  2014        PMID: 25499194     DOI: 10.1016/j.jiac.2014.11.007

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  5 in total

1.  Fatal Case of Polymicrobial Meningitis Caused by Cryptococcus liquefaciens and Mycobacterium tuberculosis Complex in a Human Immunodeficiency Virus-Infected Patient.

Authors:  César Conde-Pereira; Lia Rodas-Rodríguez; Manuel Díaz-Paz; Hilda Palacios-Rivera; Carolina Firacative; Wieland Meyer; Myriam Alcázar-Castillo
Journal:  J Clin Microbiol       Date:  2015-05-27       Impact factor: 5.948

2.  Cryptococcus liquefaciens isolated from the hand of a healthcare professional in a neonatal intensive care unit.

Authors:  Priscila Guerino Vilela Alves; Ralciane de Paula Menezes; Murilo de Oliveira Brito; Gabriel de Oliveira Faria; Nagela Bernadelli Sousa Silva; Renner Soares Cruvinel; Mário Paulo Amante Penatti; Reginaldo Dos Santos Pedroso; Denise von Dolinger de Brito Röder
Journal:  Braz J Microbiol       Date:  2021-09-20       Impact factor: 2.214

3.  The environmental yeast Cryptococcus liquefaciens produces capsular and secreted polysaccharides with similar pathogenic properties to those of C. neoformans.

Authors:  Glauber R de S Araújo; Gustavo J C Freitas; Fernanda L Fonseca; Paulo Emilio C Leite; Gustavo Miranda Rocha; Wanderley de Souza; Daniel A Santos; Susana Frases
Journal:  Sci Rep       Date:  2017-04-25       Impact factor: 4.379

4.  Cryptococcus Species Other Than Cryptococcus neoformans and Cryptococcus gattii: Are They Clinically Significant?

Authors:  Edison J Cano; Zachary A Yetmar; Raymund R Razonable
Journal:  Open Forum Infect Dis       Date:  2020-10-29       Impact factor: 3.835

5.  Comparison of Cryptococcus gattii/neoformans Species Complex to Related Genera (Papiliotrema and Naganishia) Reveal Variances in Virulence Associated Factors and Antifungal Susceptibility.

Authors:  Lana Sarita de Souza Oliveira; Luciana Magalhães Pinto; Mariana Araújo Paulo de Medeiros; Dena L Toffaletti; Jennifer L Tenor; Tânia Fraga Barros; Rejane Pereira Neves; Reginaldo Gonçalves de Lima Neto; Eveline Pipolo Milan; Ana Carolina Barbosa Padovan; Walicyranison Plinio da Silva Rocha; John R Perfect; Guilherme Maranhão Chaves
Journal:  Front Cell Infect Microbiol       Date:  2021-07-01       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.